Tobacco Regulation

Philip Morris International (PMI) supports effective evidence-based regulation of tobacco products based on the principle of harm reduction.

Learn more about our regulatory approach here.

Harm Reduction

We aim to reduce the harm caused by smoking by supporting effective evidence-based regulation of tobacco products and through our investment in developing products with the potential to reduce the risk of tobacco-related disease. Regulations can encourage harm reduction by providing frameworks and guidelines for the development and assessment of products that have the potential to reduce the risk of diseases caused by conventional cigarettes.

Learn more about harm reduction.

Health Effects of Smoking

Smoking causes many serious diseases including cardiovascular disease, lung cancer and chronic obstructive pulmonary disease. Smoking is also addictive and can be extremely difficult to quit. 

 

 

 

 

 

Learn more about the health effects of smoking.

Black market tobacco is a major and growing problem around the world. Different sources estimate the size of the illicit tobacco trade between 10% and 12% of the global cigarette market (approximately 600-650 billion cigarettes which is comparable to the size of the entire EU legal market).

Cookie Consent